Human Microbiome market is projected to grow at a CAGR of 25.0% by 2033: Visiongain
16. Juni 2023 07:24 ET
|
Visiongain Reports Ltd
As per the report by Visiongain, the Human Microbiome Market was valued at US$186.8 million in 2022 and is projected to grow at a CAGR of 25.0 % during the forecast period 2023-2033. Visiongain has...
Human Microbiome market is projected to grow at a CAGR of 25.0% by 2033: Visiongain Reports Ltd
14. März 2023 10:49 ET
|
Visiongain Reports Ltd
Visiongain has published a new report: Human Microbiome Market, (COVID-19 Impact Analysis):- Market Segment by Product (Prebiotics, Medical Drugs, Diagnostic Tests & Skin Products ), Market...
Human Microbiome market is projected to grow at a CAGR of 25.0% by 2033: Visiongain Reports Ltd
02. Februar 2023 06:00 ET
|
Visiongain Reports Ltd
Visiongain has published a new report: Human Microbiome Market, (COVID-19 Impact Analysis):- Market Segment by Product (Prebiotics, Medical Drugs, Diagnostic Tests & Skin Products ), Market...
Global Inflammatory Bowel Disease (IBD) Drugs market is projected to grow at a CAGR of 3.77% by 2031: Visiongain Research Inc
19. April 2022 11:00 ET
|
Visiongain Ltd
Visiongain has published a new report on Inflammatory Bowel Disease Drugs Market Report 2021-2031. Profiles of Inflammatory Bowel Disease Drugs and Forecasts by Drug Class (Biologics,...
Antisense Oligonucleotide (ASO) Therapeutics Market Report Up to 2031, By Visiongain Research Inc
19. April 2022 10:00 ET
|
Visiongain Ltd
Visiongain has launched a new report Antisense Oligonucleotide (ASO) Therapeutics Market Report 2021-2031: Forecasts by Therapeutic Area (Genetic Disorders, Neurological Disorders, Oncological...
Global Ophthalmic Drugs Manufacturers market is projected to reach at a market value of US$47.3 Billion by 2031: Visiongain Research Inc
13. April 2022 10:00 ET
|
Visiongain Ltd
Visiongain has published a new Lead Series report on Top 50 Ophthalmic Drugs Manufacturers Market Forecast 2021-2031. The global ophthalmic drugs manufacturers market is estimated to be valued at...
Global Mental Disorder Drugs market is projected to reach at a market value of US$58.91 Billion by 2031: Visiongain Research Inc
11. April 2022 10:00 ET
|
Visiongain Ltd
Visiongain has published a new report on Mental Disorder Drugs Market Report 2021-2031. Profiles of Mental Disorder Drugs and Forecasts by Drug Class (SSRIs, SNRIs, Atypical Antipsychotics, TCAs,...
Global Macular Degeneration (AMD) and other retinal diseases drugs market is projected to reach at a market value of US$ 40.16 Billion by 2031: Visiongain Research Inc
07. April 2022 09:00 ET
|
Visiongain Ltd
Visiongain has published a global macular degeneration (AMD) and other retinal diseases drugs market report 2021-2031.Forecasts By Indication (diabetic macular edema, diabetic retinopathy, retinal...
Global Cancer Biologics Market Research Report Up to 2031: Visiongain Research Inc
30. März 2022 10:00 ET
|
Visiongain Ltd
Visiongain has launched a new report Cancer Biologics Market Report 2021-2031:Forecasts by Treatment (Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy, Others), by Indication (Breast...
Vaccine Adjuvants Market Report Up to 2031: Visiongain Research Inc
29. März 2022 11:00 ET
|
Visiongain Ltd
Visiongain has published a forecast study of the “Vaccine Adjuvants Market Report 2021-2031”. Forecasts by Type (Pathogen, Adjuvant Emulsion, Particulate, Combination, Others,), Route of...